U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturernews2021-07-30T22:36:19+00:00July 30th, 2021|The New York Times|
Some Are Chasing Extra Vaccine Shots, While Scientists Debatenews2021-07-30T08:57:08+00:00July 30th, 2021|The New York Times|
J&J Vaccine Shelf-Life Extended by F.D.A. to Six Monthsnews2021-07-29T08:55:50+00:00July 29th, 2021|The New York Times|
Johnson & Johnson podría ser menos eficaz contra la variante deltanews2021-07-24T13:00:07+00:00July 24th, 2021|The New York Times|
Drug Distributors and J.&J. Reach $26 Billion Deal to End Opioids Lawsuitsnews2021-07-21T23:24:01+00:00July 21st, 2021|The New York Times|
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggestsnews2021-07-20T21:20:49+00:00July 20th, 2021|The New York Times|
States and Cities Near Tentative $26 Billion Deal in Opioids Casesnews2021-07-20T21:16:11+00:00July 20th, 2021|The New York Times|
Drug Companies to Pay N.Y. More Than $1 Billion to Settle Opioid Lawsuitnews2021-07-20T20:40:18+00:00July 20th, 2021|The New York Times|
Johnson & Johnson Recalls Sunscreen Because of Benzene Tracesnews2021-07-15T01:19:37+00:00July 15th, 2021|The New York Times|
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccinenews2021-07-13T02:28:00+00:00July 13th, 2021|The New York Times|
